Hengrui Pharmaceutical 2023 Annual General Meeting of Shareholders Meeting Materials
Apr 29 12:00 ET
Hengrui Pharmaceutical's indicative announcement on acceptance of drug marketing license applications
Apr 25 12:00 ET
Hengrui Pharmaceutical's Announcement on Obtaining Approval Notice for Drug Clinical Trials
Apr 25 12:00 ET
Hengrui Pharmaceutical's Announcement on Subsidiaries Obtaining Approval Notices for Drug Clinical Trials
Apr 22 12:00 ET
Hengrui Pharmaceutical's Announcement on Subsidiaries Obtaining Approval Notices for Drug Clinical Trials
Apr 18 12:00 ET
Hengrui Pharmaceutical's Announcement on the Company's Drug Obtaining Fast Track Qualification from the US FDA
Apr 18 12:00 ET
Hengrui Pharmaceutical's Announcement on Subsidiaries Obtaining Approval Notices for Drug Clinical Trials
Apr 18 12:00 ET
Hengrui Pharmaceutical's Announcement on Holding Results Briefings for the First Quarter of 2023 and 2024
Apr 18 12:00 ET
Announcement of Resolutions of the 7th Meeting of the 9th Board of Directors of Hengrui Pharmaceutical
Apr 17 12:00 ET
Hengrui Pharmaceutical Board Audit Committee Implementation Rules (2024 Revision)
Apr 17 12:00 ET
Hengrui Pharmaceutical Board Nomination Committee Implementation Rules (2024 Revision)
Apr 17 12:00 ET
Hengrui Pharmaceutical Board Strategy Committee Implementation Rules (2024 Revision)
Apr 17 12:00 ET
Hengrui Pharmaceutical Independent Director Work System
Apr 17 12:00 ET
Hengrui Pharmaceutical Board Remuneration and Assessment Committee Implementation Rules (2024 Revision)
Apr 17 12:00 ET
Hengrui Pharmaceutical's 2024 “Improve Quality, Increase Efficiency, and Value Rewards” Action Plan
Apr 17 12:00 ET
Summary of Hengrui Pharmaceutical's 2023 Annual Report
Apr 17 12:00 ET
Hengrui Pharmaceutical 2023 Annual Report
Apr 17 12:00 ET
Hengrui Pharmaceutical 2023 Audit Report
Apr 17 12:00 ET
Special note on the 2023 non-operating capital occupation and other related capital transactions of Jiangsu Hengrui Pharmaceutical Co., Ltd.
Apr 17 12:00 ET
Hengrui Pharmaceutical 2023 Independent Director Debriefing Report (Zeng Qingsheng)
Apr 17 12:00 ET
No Data
No Data